FTDI
ONC

First Trust Direct Indexing’s BeOne Medicines Ltd ONC Stock Holding History

First Trust Direct Indexing’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,808
Closed -$506K – 858
2023
Q4 		$506K Sell
2,808
-433
-13% -$78.3K 0.05% 442
2023
Q3 		$583K Sell
3,241
-330
-9% -$65.3K 0.07% 348
2023
Q2 		$637K Sell
3,571
-620
-15% -$143K 0.07% 336
2023
Q1 		$903K Buy
4,191
+270
+7% +$64.8K 0.11% 240
2022
Q4 		$862K Buy
3,921
+2,142
+120% +$393K 0.11% 241
2022
Q3 		$240K Sell
1,779
-281
-14% -$48.3K 0.04% 526
2022
Q2 		$333K Buy
+2,060
New +$322K 0.05% 443

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return